Aeglea BioTherapeutics AGLE 深 沪
已收盘 11-27 16:00:00 美东时间
12.01
0.000
0.00%
华盛通- 最 高--
- 今 开--
- 成交量 0股
- 最 低 --
- 昨 收 12.01
- 总市值 4862.49万
- 52周最高 24.00
- 市盈率 静 --
- 换手率 0.00%
- 52周最低 2.66
- 委 比 0.00%
- 总股本 404.87万
- 历史最高 318.75
- 量 比 0
- 振 幅 0.00%
- 历史最低 2.66
- 每 手 1
- 风险率 0.00%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多新浪财经ESG：AGLE 路孚特（Refinitiv）ESG评级调降至D+
新浪财经ESG评级中心提供包括资讯、报告、培训、咨询等在内的14项ESG服务，助力上市公司传播ESG理念，提升ESG可持续发展表现。点击查看【 ESG评级中...
2024-06-24 07:00
Alto Neuroscience appoints Michael Hanley as COO
Alto Neuroscience (NYSE:ANRO) said it has appointed industry veteran Michael Hanley as chief operating officer. Hanley has over 25 years of leadership experience in the life sciences industry, and mos...
2024-05-21 20:21
凯雷Q3持仓：医疗诊断巨头Quidel(QDEL.US)稳坐第一重仓股 建仓Complete Solaria(CSLR.US)
根据美国证券交易委员会披露，全球另类资产管理巨头凯雷递交了截止至2023年9月30日的第三季度持仓报告。
2023-11-15 15:13
Aeglea BioTherapeutics to Participate in Upcoming September Conference
WALTHAM, Mass., Sept. 14, 2023 /PRNewswire/ -- Aeglea BioTherapeutics, Inc. ("Aeglea") (Nasdaq: AGLE), a biotechnology company advancing a pipeline of antibody therapeutics with the potentia...
2023-09-15 05:03
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Gainers Asensus Surgical (AMEX:ASXC) shares rose 37.2% to $0.4 during Thursday...
2023-09-07 21:06
Aeglea BioTherapeutics Announces 1-For-25 Reverse Stock Split
Aeglea BioTherapeutics, Inc. ("Aeglea") (NASDAQ:AGLE), a biotechnology company advancing a pipeline of antibody therapeutics with the potential to transform the treatment of inflammatory bowel disease
2023-09-07 20:48
Aeglea BioTherapeutics Expands Executive Leadership Team with Appointment of Industry Veterans Scott Burrows and Heidy Abreu King-Jones
Scott Burrows, former Arcutis Biotherapeutics CFO, assumes role as Chief Financial Officer Heidy Abreu King-Jones, former Provention Bio CLO & Corporate Secretary, assumes role as Chief Leg...
2023-09-05 19:00
Wells Fargo Maintains Equal-Weight on Aeglea BioTherapeutics, Raises Price Target to $0.5
Wells Fargo analyst Yanan Zhu maintains Aeglea BioTherapeutics (NASDAQ:AGLE) with a Equal-Weight and raises the price target from $0.35 to $0.5.
2023-08-16 20:36
Aeglea BioTherapeutics Analyst Ratings
What is the target price for Aeglea BioTherapeutics (AGLE)? The latest price...
2023-07-25 17:18
